Dr. Martens appointed Giles Wilson as chief financial officer, effective at the start of 2024.
Wilson, most recently, was CFO at Scottish spirits company William Grant & Sons, the makers of Glenfiddich Scotch Whisky, Balvenie Whisky and Hendrick’s Gin. Before that, Wilson was CFO and subsequently CEO of aviation services business John Menzies.
Wilson will replace Jon Mortimore, who is retiring from the company as previously announced but agreed to stay on until the end of the financial year.
Paul Mason, the company’s chair, stated, “Giles is a very capable finance leader with extensive experience in a number of sectors, and, most recently, his time in the branded spirits industry has given him a good grounding in global brands and wholesale distribution management. His knowledge of the public markets will be a valuable asset to the team as Dr. Martens continues its growth in the listed environment.”
“Giles brings a range of complementary skills and past experience that is highly relevant to our brand-first strategy. I am looking forward to working with him on the next phase of Dr. Martens’ journey to become a 2 billion pounds revenue footwear brand,” added Kenny Wilson, Dr. Martens CEO.
Wilson said, “I am excited to be joining at such an important stage in the company’s growth, and I am looking forward to working with Kenny and the team to drive the strategy forward.”
Photos courtesy Dr. Martens
